Inactive Instrument

Calendar Peregrine Pharmaceuticals Nasdaq

Equities

US7136615025

Chart calendar Peregrine Pharmaceuticals

bf4b6b26d2fb.S7JGpkE5LGV84Pjvvzez-HH8uJGnOmxI0fb1mikE03w.LssRzCpvVCIXsM-w1lzcqRSqyPTkSQsYmKW_9nlHuzQn8xXfLGx_HCW_vQ~674a700635c2f99251bd7d5af0b64506

Upcoming events on Peregrine Pharmaceuticals

2024-04-29 04:30 pm Q3 2024 Earnings Call
2024-05-13 RBC Capital Markets Global Healthcare Conference
2024-06-25 Q4 2024 Earnings Release (Projected)
2024-09-04 Q1 2025 Earnings Release (Projected)
2024-12-02 Q2 2025 Earnings Release (Projected)
2025-03-16 Q3 2025 Earnings Release (Projected)

Past events on Peregrine Pharmaceuticals

2024-04-24 05:25 pm Q3 2024 Earnings Release
2023-12-07 04:30 pm Q2 2024 Earnings Call
2023-12-07 04:05 pm Q2 2024 Earnings Release
2023-10-23 01:00 pm Annual General Meeting
2023-10-03 11:00 am RBC Capital Markets CDMO Conference
2023-09-07 04:30 pm Q1 2024 Earnings Call
2023-09-07 04:05 pm Q1 2024 Earnings Release
2023-06-21 04:30 pm Q4 2023 Earnings Call
2023-06-21 04:07 pm Q4 2023 Earnings Release
2023-05-17 08:30 am RBC Global Healthcare Conference
2023-03-13 04:30 pm Q3 2023 Earnings Call
2023-03-13 04:05 pm Q3 2023 Earnings Release
2022-12-06 04:30 pm Interim 2023 Earnings Call
2022-12-06 04:05 pm Interim 2023 Earnings Release
2022-11-09 03:50 pm Credit Suisse Healthcare Conference
2022-10-18 01:00 pm Annual General Meeting
2022-10-03 12:15 pm RBC Global CDMO Conference
2022-09-14 12:55 pm Morgan Stanley Global Healthcare Conference
2022-09-06 04:30 pm Q1 2023 Earnings Call
2022-09-06 04:05 pm Q1 2023 Earnings Release

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
53,6
52,4
2.36%
59,7
55,9
6.86%
95,9
89,9
6.67%
120
117
1.93%
149
148
0.6%

139

EBITDA
Million USD
Released
Forecast
Spread
-2,88
0,00
-
-7,49
-7,76
3.38%
15,7
14,3
9.92%
30,4
27,2
12.06%
21,7
20,3
6.72%

5,61

EBIT
Million USD
Released
Forecast
Spread
-5,62
-6,60
14.82%
-10,6
-13,5
21.34%
12,2
10,9
12.16%
15,4
18,2
-15.17%
3,60
3,16
13.88%

-17,7

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-5,34
-11,3
52.74%
-10,5
-10,7
1.95%
11,2
11,0
1.63%
12,7
12,1
4.65%
2,00
1,48
35.8%

-21,1

Net income
Million USD
Released
Forecast
Spread
-8,90
-11,0
19.08%
-15,2
-14,5
-4.65%
3,32
5,61
-40.89%
128
12,1
955.26%
0,56
0,78
-28.25%

-16,3

EPS
USD
Released
Forecast
Spread
-0,16
-0,18
8.57%
-0,27
-0,33
19%
0,06
0,09
-35.71%
1,84
0,19
885.7%
0,01
0,01
-20%

-0,26

Announcement Date27/06/1930/06/2029/06/2129/06/2221/06/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
31,5
25,3
24.51%
31,2
29,0
7.83%
36,7
33,4
9.71%
34,8
32,1
8.41%
38,0
36,3
4.68%
39,8
38,9
2.32%
37,7
36,1
4.55%
25,4
33,2
-23.55%
33,8
34,3
-1.39%

41,8


42,1


35,0


41,7


49,7

EBITDA
Million USD
Released
Forecast
Spread
4,29
5,20
-17.38%
5,89
4,40
33.8%
6,19
5,92
4.56%
1,89
5,24
-64.03%
7,37
2,86
157.56%
6,27
4,91
27.66%
2,79
3,72
-24.88%
-5,97
1,77
-437.64%
-1,12
2,18
-151.22%

5,50


5,44


1,74


6,12


11,1

EBIT
Million USD
Released
Forecast
Spread
3,27
3,00
8.98%
1,07
2,03
-47.45%
2,74
2,60
5.33%
-2,68
0,36
-853.93%
2,72
-2,24
221.26%
0,83
0,41
102.8%
-2,16
-1,61
-34.18%
-11,2
-4,40
-154.92%
-4,00
-3,38
-18.47%

-1,09


-1,05


-4,90


-0,83


3,23

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
2,25
2,39
-5.78%
0,59
0,02
3568.75%
2,27
1,11
103.87%
-3,24
-0,15
-2132.01%
2,53
-2,83
189.42%
0,45
-0,07
776.23%
-2,68
-2,20
-21.86%
-11,9
-5,02
-136.89%
-7,06
-4,70
-50.15%

-1,85


-4,05


-7,90


-3,83


0,23

Net income
Million USD
Released
Forecast
Spread
2,25
2,39
-5.78%
116
0,02
722387.5%
1,56
1,01
55.06%
-1,16
-0,13
-762.69%
0,46
-2,30
120.02%
-0,31
-0,07
-333.68%
-2,09
-1,73
-21.18%
-9,51
-4,03
-135.98%
-6,01
-3,72
-61.66%

-1,29


-3,04


-5,92


-2,88


0,17

EPS
USD
Released
Forecast
Spread
0,04
0,04
0%
1,65
0,00
49649.55%
0,02
0,01
50.04%
-0,02
-0,01
-300%
0,01
-0,04
128.57%
0,00
0,00
-
-0,03
-0,02
-28.59%
-0,15
-0,06
-140%
-0,09
-0,06
-56.52%

-0,02


-0,05


-0,09


-0,04


0,00

Announcement Date08/03/2229/06/2206/09/2206/12/2213/03/2321/06/2307/09/2307/12/2306/03/24-----
  1. Stock Market
  2. Equities
  3. CDMO Stock
  4. Stock
  5. Calendar Peregrine Pharmaceuticals